The therapeutic effects of recombinant adenovirus RA538 on human gastric carcinoma cells in vitro and in vivo

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

203

HTML

1953

Figures (1-6)

225

Tables (1-2)

195

Sum=2576

Dec 15, 2000 (publication date) through Dec 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Articles

World J Gastroenterol. Dec 15, 2000; 6(6): 855-860
Published online Dec 15, 2000. doi: 10.3748/wjg.v6.i6.855

Full Size Figure Download Figure

Figure 3 Western blot analysis c-myc and β-actin expression of SGC7901 cell infected with Ad-RA538. Lane 1: control, Lane 2-5: 1d, 3d, 5d, 7d.

Citation: Chen JP, Lin C, Xu CP, Zhang XY, Wu M. The therapeutic effects of recombinant adenovirus RA538 on human gastric carcinoma cells in vitro and in vivo. World J Gastroenterol 2000; 6(6): 855-860
URL: https://www.wjgnet.com/1007-9327/full/v6/i6/855.htm
DOI: https://dx.doi.org/10.3748/wjg.v6.i6.855